Creativity and knowledge

With this we work for the health of women

With new concepts

to new solutions

From all perspectives

The Women's Health Blog
+++ BREAKING NEWS +++ THE PHASE IIb/III STUDY, WHICH WAS LAUNCHED IN NOVEMBER 2019, IS NOW COMPLETED
+++ BREAKING NEWS +++ THE PHASE IIb/III STUDY, WHICH WAS LAUNCHED IN NOVEMBER 2019, IS NOW COMPLETED
November 4, 2022

Prof-001 (Candiplus®) - Phase 3 kurz vor Abschluss

Die Ergebnisse werden ausgewertet – We will keep you up to date!

Women among themselves - News in the blog on women's health

06.04.2022

Prevention: How to prevent vaginal fungus

24.03.2022

The taboo topic of "women's diseases": Why women are neglected in research

PROFEM - Working for Women's Health

MISSION

CREATIVITY plus KNOWLEDGE

With this combination, we are taking medicine for women to a new level!

PROFEM solves therapeutic problems through systemic treatment concepts. Based on the latest pharmacological findings, treatment successes are made possible by combining proven medicinal substances in highly efficient forms of application where there was previously no cure.

# BREAK THE TABOO

For a large number of diseases that exclusively or primarily affect women, there are still no adequate treatment options. This is probably because no one talks about these diseases, they don't even know they exist! Both the number of people affected and the extent of suffering are underestimated. Our goal is to change this untenable state of affairs, through our commitment to research, but also through communication! 

ACTIVITIES

Chronic infections of the bladder and lower genital tract are diseases affecting hundreds of millions of women worldwide. The formation and persistence of biofilms very often determine the disease process in such diseases. To date, the treatment of biofilm-associated diseases remains a largely unsolved medical problem. With the Candiplus® lead project, ProFem is introducing an innovative therapy concept for the treatment of such infections.

AWARDS

"Best project"

- Fempower 2012

"One of the 3 best business concepts".

- Best of Biotech 2010

SUPPORTED BY: